Overcoming challenges of translating deep-learning models for glioblastoma: the ZGBM consortium

Haris Shuaib,Gareth J Barker,Peter Sasieni,Enrico De Vita,Alysha Chelliah,Roman Andrei,Keyoumars Ashkan,Erica Beaumont,Lucy Brazil,Chris Rowland-Hill,Yue Hui Lau,Aysha Luis,James Powell,Angela Swampillai,Sean Tenant,Stefanie C Thust,Stephen Wastling,Tom Young,Thomas C Booth

2024-05-07

Abstract:Objective: To report imaging protocol and scheduling variance in routine care of glioblastoma patients in order to demonstrate challenges of integrating deep-learning models in glioblastoma care pathways. Additionally, to understand the most common imaging studies and image contrasts to inform the development of potentially robust deep-learning models. Methods: MR imaging data were analysed from a random sample of five patients from the prospective cohort across five participating sites of the ZGBM consortium. Reported clinical and treatment data alongside DICOM header information were analysed to understand treatment pathway imaging schedules. Results: All sites perform all structural imaging at every stage in the pathway except for the presurgical study, where in some sites only contrast-enhanced T1-weighted imaging is performed. Diffusion MRI is the most common non-structural imaging type, performed at every site. Conclusion: The imaging protocol and scheduling varies across the UK, making it challenging to develop machine-learning models that could perform robustly at other centres. Structural imaging is performed most consistently across all centres. Advances in knowledge: Successful translation of deep-learning models will likely be based on structural post-treatment imaging unless there is significant effort made to standardise non-structural or peri-operative imaging protocols and schedules.

Image and Video Processing,Machine Learning

What problem does this paper attempt to address?

The paper attempts to address the challenges faced in applying deep learning models in the clinical management of glioblastoma. Specifically, these challenges include:

1. **Lack of large-scale external validation**: Existing deep learning models are insufficient in terms of large-scale external validation, which limits their application in clinical practice.
2. **Dependence on advanced imaging techniques**: Many deep learning models rely on advanced imaging techniques that are not commonly used in routine clinical practice, such as perfusion MRI, further hindering their clinical translation.
3. **Differences in imaging protocols and schedules**: There are significant differences in imaging protocols and schedules between different medical institutions, making it difficult to develop machine learning models that can robustly operate across multiple centers.

To address these challenges, the ZGBM (Zeugmatography for Glioblastoma) Alliance was established. This alliance consists of leading neuro-oncology centers in the UK and aims to improve the treatment of glioblastoma by collecting and analyzing large amounts of patient data. The goals of the alliance include:

- Developing AI models capable of distinguishing between progression and pseudoprogression and understanding the imaging evolution of tumors post-treatment.
- Testing these AI models in independent prospective cohorts to ensure high accuracy across different MRI scanner manufacturers and scanning parameters.
- Reducing the impact of imaging differences between institutions by limiting input data to routinely acquired structural imaging data and integrating image standardization techniques.
- Incorporating treatment data such as radiotherapy plans into model evaluation to improve model accuracy.
- Developing a MONAI Deploy application to facilitate the easy integration of these models into clinical workflows.

Through these efforts, the ZGBM Alliance hopes to advance the practical application of deep learning models in the clinical management of glioblastoma.